Carter's Vs. Neurogene Industry Stock Comparison

Sell

28

CRI
Carter's

Last Price:

54.52

Seasonality Move:

4.35%

Sell

5

NGNE
Neurogene

Last Price:

39.96

Seasonality Move:

50.43%

Sell

28

Carter's (CRI) is a Sell

Is Carter's a Buy, Sell or Hold?

The current Carter's [CRI] share price is $53.71. The Score for CRI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
CRI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

5

Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

CRI Stock Price Chart

What is Carter's's stock price today?

The Carter's share price today is $53.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRI is experiencing slight buying pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

The Neurogene share price today is $39.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

CRI Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.23	Sell
Relative Strength Index (14 RSI):	36.28	Sell
Chaikin Money Flow:	120750	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(52.93 - 64.51)	Sell
Bollinger Bands (100):	(58.09 - 67.47)	Sell

NGNE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	2.3	Buy
Relative Strength Index (14 RSI):	39.1	Sell
Chaikin Money Flow:	-346626	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(43.29 - 61.53)	Sell
Bollinger Bands (100):	(34.11 - 50.51)	Sell

CRI Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	52.72	Buy
20-day SMA:	57.74	Sell
50-day SMA:	62.91	Sell
200-day SMA:	68.85	Sell
8-day EMA:	53.33	Buy
20-day EMA:	56.36	Sell
50-day EMA:	60.41	Sell
200-day EMA:	66.13	Sell

NGNE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	60.39	Sell
20-day SMA:	53.17	Sell
50-day SMA:	46.66	Sell
200-day SMA:	38.93	Buy
8-day EMA:	54.03	Sell
20-day EMA:	53.18	Sell
50-day EMA:	48.36	Sell
200-day EMA:	38.47	Buy

Carter's Earnings Growth & CRI Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.30 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Carter's Technical Analysis

	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13
	Oct		Nov
	31	01	04	05	06	07	08	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13
	Oct		Nov
	31	01	04	05	06	07	08	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):